Briefing Stayed In 1 Patent Case As Rehearing Bid Considered In Another

Mealey's (April 12, 2023, 7:12 AM EDT) -- WASHINGTON, D.C. — A dispute between an unsuccessful petitioner for inter partes review (IPR) and a university over a patent covering the production of nicotinamide riboside (NR) and compositions containing NR has been stayed while the Federal Circuit U.S. Court of Appeals addresses a recent request for rehearing by the patent owner of a decision declaring the technology patent-ineligible....

Attached Documents

Related Sections